Multiple sclerosis marker identified:
This article was originally published in Clinica
A new marker for multiple sclerosis (MS) has been identified by an Italian-German research team. The protein marker, CD39, is thought to completely disappear in patients with the disease. CD39 is found on the surface of a subgroup of protective immune cells - suppressor cells - which are strikingly reduced in MS patients. In normal individuals, CD39 is thought to curb inflammation in the central nervous system during the course of the disease. The research team, based at the Fondazione Santa Lucia, in Rome, Italy, and the Max Delbruck Center for Molecular Medicine, in Berlin-Buch, Germany, hopes that the future will show whether the marker will become clinically useful. The findings appear in the August 15 issue of Blood.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.